Biohaven Pharmaceuticals has landed reality TV star Khloe Kardashian as an influencer of a new migraine drug. The KUPWTK star is working with Biohaven Pharmaceuticals to promote its newly launched migraine drug, Nurtec ODT. “This campaign is all about patients” and Kardashian “has been very vocal about how she’s struggled with migraines since the sixth … Continue reading “Khloe Kardashian Signs Up as Influencer for Biohaven Pharmaceuticals Migraine Drug”
Biotech & Pharma
Pfizer and BioNtech Are Granted FDA Fast Track Designation for SARS-COV-2 Vaccine Candidates
Pharmaceutical giant Pfizer Inc. and BionTech SE made an exciting joint announcement on Monday that…
Bayer Has Reached An Over $10B Settlement over Roundup Cancer Lawsuits
German multinational pharmaceutical and life sciences company Bayer has reached an over $10 billion settlement…
CEO of Moderna Thinks Company’s COVID-19 Vaccine is Likely to be Successful
Moderna CEO Stéphane Bancel sees ‘high probability’ of success with the company's Covid-19 vaccine. The…
Novavax to Raise Capital through $200M Stock Offering to Fund COVID-19 Vaccine
American vaccine development company Novavax announced on Monday that it would raise fresh capital through…
Novus Therapeutics Plummets After Disappointing Drug Trial Results
Shares of Novus Therapeutics were on a downward spiral on Monday, losing almost half of…
Arca Biopharma Explodes Higher After Announcing Plans to Test a Coronavirus Drug
Shares of Arca Biopharma were skyrocketing on Thursday and nearly quintupled in value after the…
Amgen and Alexion Pharmaceuticals Reach Agreement in Patent Battle
Shares of Alexion Pharmaceuticals were soaring on Thursday and Friday after the company along with…
Moderna Shares Soar on Positive Results on Early Stage Coronavirus Vaccine Trial
Shares of Moderna were surging in Monday's trading session after the company revealed positive data…
Pfizer is Planning to Test Coronavirus Vaccine on Thousands of People
With the coronavirus pandemic still going and with no end in sight, drug makers are…
Crispr Therapeutics Explodes 15% After New Blood Disease Drug Gets Fast-Track
Shares of Crispr Therapeutics were on the rise since Monday, shooting up almost 15% after…
Mylan CEO Says Company Had “Minimal Disruption” During Coronavirus Pandemic
According to Mylan CEO Heather Bresch, the company's global supply chain has helped it experience…
FDA is in Discussions with Gilead to Make Remdesivir Available As Quickly as Possible
At the rate of how many are being infected with coronavirus and how many are…
Biogen Tumbles After Delay of Alzheimer’s Treatment Submission
Shares of biotech giant Biogen were falling on Wednesday after the company said it would…
